Board of Aurobindo Pharma approves acquisition of 26% stake in a solar energy company
At meeting held on 06 February 2025
The Board of Aurobindo Pharma at its meeting held on 06 February 2025 has approved to enter into a power purchase agreement with Swarnaaskshu Solar Power (Swarnaaskshu), a company under incorporation, for purchase of solar power under the captive power policy of the Government of Telangana and in this connection will be acquiring upto 26% of the paid-up equity share capital of Swarnaaskshu.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content